Delivery Order SPE2DB24D2101-SPE2DB25FKMWW
- Not listed
- Amerisourcebergen Drug Corp has received a $3,480.24 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply VAXELIS vaccine syringes in quantities of 0.5 milliliters. The delivery order was awarded on December 7, 2023 against an existing indefinite delivery contract with no set-aside designation specified. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania with completion by December 8, 2023. As a leading...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,740.12 from the Defense Logistics Agency (DLA) Troop Support Medical to supply VAXELIS vaccines in 0.5mL syringes. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 15, 2023. As a prime contractor, Amerisourcebergen provides pharmaceuticals and medical supplies to DLA Troop Support Medical in support of military treatment facilities. No...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,870.10 on August 4, 2025, for the supply of IPOL Vial 5ML pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This $3,586.26 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS Vaccine in 0.5mL vials, with a completion date of May 14, 2024. This contract award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $6,394.80 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ML) with a firm fixed price and an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract was issued on July 29, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,527.20 Firm Fixed Price Delivery Order is for the procurement of VAXELIS vaccine vials (0.5ML) to support federal healthcare programs. The contract has an ultimate completion date of December 14, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $1,239.24 by the Defense Logistics Agency (DLA) Troop Support Medical to supply 0.5ML VAXELIS vaccine syringes. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,271.65 by the Defense Logistics Agency on July 22, 2025, for the supply of ProQuad vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,439.40 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed price, competitively awarded contract (No. 4568932617) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $31,793.84 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMWWDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,466.96 firm fixed-price delivery order by the Defense Logistics Agency on July 29, 2025, for the supply of Vaxelis vaccine vials (0.5mL). The award represents a competitively awarded, non-set-aside contract with an ultimate completion date of July 30, 2025, and performance location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, positioning the company as a critical global pharmaceutical supplier for military healthcare programs. The contract supports the Defense Logistics Agency's medical supply chain operations, delivering vaccines for use across military and federal healthcare systems. AmerisourceBergen's extensive portfolio of federal medical procurement demonstrates its established capability to fulfill diverse pharmaceutical requirements through competitive processes. The firm fixed-price structure and rapid completion timeline reflect the standard operational model for delivery orders issued under the broader DLA pharmaceutical prime vendor agreement, which enables responsive sourcing of medical commodities for Department of Defense beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 7/29/25 |